Reify Health vs Tempus

Side-by-side comparison of AI visibility scores, market position, and capabilities

Tempus leads in AI visibility (74 vs 54)
Reify Health logo

Reify Health

ChallengerLife Sciences & BioTech

Clinical Trial Operations & Enrollment

Reify Health raised $220M Series D at $4.8B valuation; OneStudyTeam and Care Access accelerate clinical trial site operations and decentralized enrollment; $407M total raised to bridge diversity gap in trials.

AI VisibilityBeta
Overall Score
C54
Category Rank
#27 of 198
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
48
Perplexity
53
Gemini
53

About

Reify Health is a clinical trial acceleration company whose two platform arms — OneStudyTeam and Care Access — address the two biggest friction points in clinical research: site operations efficiency and patient enrollment reach. OneStudyTeam provides workflow software that automates the administrative burden on clinical research sites, enabling faster startup, better sponsor-site collaboration, and compliant data capture throughout trial execution. Care Access operates a decentralized clinical trial infrastructure that brings research directly to patients in underserved communities, expanding the diversity and geographic reach of clinical study populations.

Full profile
Tempus logo

Tempus

LeaderLife Sciences & BioTech

AI-Enabled Precision Medicine

Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.

AI VisibilityBeta
Overall Score
B74
Category Rank
#11 of 198
AI Consensus
68%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
68
Gemini
80

About

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.

Full profile

AI Visibility Head-to-Head

54
Overall Score
74
#27
Category Rank
#11
86
AI Consensus
68
stable
Trend
stable
48
ChatGPT
71
53
Perplexity
68
53
Gemini
80
49
Claude
77
50
Grok
69

Key Details

Category
Clinical Trial Operations & Enrollment
AI-Enabled Precision Medicine
Tier
Challenger
Leader
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.